Colorectal cancer: Review of signaling pathways and associated therapeutic strategies

被引：8

作者：

Leiphrakpam, Premila D. ^{[1
,2
]}

Rajappa, Senthil J. ^{[3
]}

Krishnan, Mridula ^{[4
]}

Batra, Rishi ^{[5
]}

Murthy, Shilpa S. ^{[6
]}

Are, Chandrakanth ^{[1
,2
,7
]}

机构：

[1] Univ Nebraska Med Ctr, Coll Med, Grad Med Educ, Omaha, NE USA

[2] Univ Nebraska Med Ctr, Coll Med, Dept Surg, Div Surg Oncol, Omaha, NE USA

[3] Basavatarakam Indo Amer Canc Hosp, Med Oncol, Hyderabad, Telangana, India

[4] Univ Nebraska Med Ctr, Coll Med, Dept Internal Med, Div Oncol & Hematol, Omaha, NE USA

[5] Univ Nebraska Med Ctr, Coll Med, Dept Surg, Div Gen Surg, Omaha, NE USA

[6] Mem Sloan Kettering Canc Ctr, Div Surg Oncol, Global Canc Dispar Initiat, New York, NY USA

[7] Univ Nebraska Med Ctr, Coll Med, Dept Surg, Div Surg Oncol, Omaha, NE 68198 USA

来源：

JOURNAL OF SURGICAL ONCOLOGY | 2023年 / 127卷 / 08期

关键词：

biomarkers; colorectal cancer; targeted therapy; RANDOMIZED PHASE-III; FOLFIRI PLUS BEVACIZUMAB; MOLECULAR SUBGROUP ANALYSES; FACTOR-BETA RECEPTOR; KRAS WILD-TYPE; OPEN-LABEL; 1ST-LINE TREATMENT; FOLFOXIRI PLUS; DOUBLE-BLIND; MAINTENANCE TREATMENT;

D O I：

10.1002/jso.27295

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Tumor profiling and targeted therapy revolutionized the treatment strategies of metastatic colorectal cancer (mCRC) in the last decade. The heterogeneity of CRC tumors plays a critical role in the development of treatment resistance, which underscores the need to understand the molecular mechanism involved in CRC to develop novel targeted therapeutic strategies. This review provides an overview of the signaling pathways driving CRC, the existing targeted agents, their limitations, and future trends.

引用

页码：1277 / 1295

页数：19

共 50 条

[31] FOXO Signaling Pathways as Therapeutic Targets in Cancer
Farhan, Mohd
Wang, Haitao
Gaur, Uma
Little, Peter J.
Xu, Jiangping
Zheng, Wenhua
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2017, 13 (07): : 815 - 827
[32] Gastric Cancer Signaling Pathways and Therapeutic Applications
Wu, Mingfang
Yuan, Shiman
Liu, Kai
Wang, Chenyu
Wen, Feng
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
[33] Signaling pathways and therapeutic interventions in gastric cancer
Zi-Ning Lei
Qiu-Xu Teng
Qin Tian
Wei Chen
Yuhao Xie
Kaiming Wu
Qianlin Zeng
Leli Zeng
Yihang Pan
Zhe-Sheng Chen
Yulong He
Signal Transduction and Targeted Therapy, 7
[34] Signaling pathways and therapeutic interventions in gastric cancer
Lei, Zi-Ning
Teng, Qiu-Xu
Tian, Qin
Chen, Wei
Xie, Yuhao
Wu, Kaiming
Zeng, Qianlin
Zeng, Leli
Pan, Yihang
Chen, Zhe-Sheng
He, Yulong
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
[35] Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms
Novellasdemunt, Laura
Antas, Pedro
Li, Vivian S. W.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2015, 309 (08): : C511 - C521
[36] Cancer-associated signaling pathways influence the HLA-immunopeptidome of colorectal carcinoma
Haen, S. C. P.
Kowalewski, D. J.
Backert, L.
Bernhardt, J.
Schuster, H.
Dengler, F.
Kopp, H. -G.
Wagner, S.
Koenigsrainer, I.
Beckert, S.
Kohlbacher, O.
Koenigsrainer, A.
Kanz, L.
Rammensee, H. -G.
Stevanovic, S.
Loeffler, M. W.
ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 124 - 124
[37] Promising therapeutic strategies for colorectal cancer treatment
不详
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 : S194 - S198
[38] Colorectal cancer: Diagnostic and therapeutic strategies.
Vaillant, JC
MEDECINE NUCLEAIRE, 1996, 20 (4-5): : 266 - 269
[39] Luteolin, a Bioflavonoid Inhibits Colorectal Cancer through Modulation of Multiple Signaling Pathways: A Review
Pandurangan, Ashok Kumar
Esa, Norhaizan Mohd
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (14) : 5501 - 5508
[40] Signaling Pathways in Inflammation and Cardiovascular Diseases: An Update of Therapeutic Strategies
Cucu, Ioana
IMMUNO, 2022, 2 (04): : 630 - 650

← 1 2 3 4 5 →